AC Immune SA

ACIU | NASDAQ | 2 Sledující

$2.04

17.92%

$0.31

Sledovat

Overview Metrics Financials

Company Quality

Profitability Score

15/100

Solvency Score

46/100

Dividends

Dividends data currently unavailable.

Earnings

8/5/2025

in 58 days

$3M

Revenue est.

-0.18

EPS est.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Biotechnology

Průmysl

Dr. Andrea Pfeifer Ph.D.

CEO

133

Zaměstnanci

Lausanne

Centrála

Země

Key Metrics TTM

Valuation

Market cap.

$166M

Enterprise Value

$151M

Price to Earnings

-3.23

Price to Sales

5.86

Price to Book

1.78

Price to Cash Flow

3.66

Profitability

Return on Assets

-24.67%

Return on Equity

-45.22%

Return on Invested Capital

-45.79%

Gross Margin

39.44%

Operating Margin

-182.62%

Net Margin

-184.05%

Liquidity

Quick Ratio

1.53

Current Ratio

1.53

Cash Ratio

0.20

Inventory Turnover

0.00

Asset Turnover

0.13

Total Liabilities

$116M

Solvency

Debt to Assets

0.02

Debt to Equity

N/A

Interest Coverage

-342.3

Equity Ratio

0.45

Long-term Debt to Cap.

0.00

Altman Z-Score

-2.08

Performance

Earnings Waterfall

Debt level and coverage

Earnings

Feed

There are no posts to show right now.